MarketPeel
Insider Trading Intelligence
MT

Miranda Jayne Toledano

DERM
DIRECTOR · JOURNEY MEDICAL CORP · CIK 0001686530
FILING MIX · LIFETIME100%/0%
BUYS
29
SELLS
0
TOTAL VALUE
$125.8K
COMPANIES
4
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
2,401,742
AVG SELL PX
TRADE KIND
SHOWING 29 / 29
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Miranda Jayne Toledano, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+14.29%-1.52%-0.76%-0.76%-8.04%
14d7+42.86%-1.38%-0.92%-0.46%-9.79%
30d7+42.86%+7.61%-1.46%+9.07%-5.09%
60d7+42.86%+16.69%-0.56%+17.25%-14.15%
90d7+42.86%+43.83%+2.14%+41.69%-1.92%
180d7+42.86%+56.12%+1.79%+54.32%-14.04%
1y7(1 pending)+66.67%+71.58%+10.40%+61.18%+37.64%
2y7(1 pending)+66.67%+99.08%+32.03%+67.05%+87.39%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
DERM · 168,618 shares · as of Jul 1, 2026
042,15584,309126,464168,6182023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 29 buys / 0 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
DERM
JOURNEY MEDICAL CORP
PURCHASEGRANT
Stock grant
50,000168,618Jul 1, 2026Jul 2, 2026View →
DERM
JOURNEY MEDICAL CORP
PURCHASEGRANT
Stock grant
10,000118,618Jun 25, 2026Jun 29, 2026View →
ENTX
ENTERA BIO LTD.
PURCHASE
Chief Executive Officer
11,000$1.81$19.9K426,575Dec 29, 2025Dec 30, 2025View →
DERM
JOURNEY MEDICAL CORP
PURCHASEGRANT
Stock grant
20,000108,618Aug 5, 2025Aug 7, 2025View →
ENTX
ENTERA BIO LTD.
PURCHASEGRANT
Stock grant
136,842371,715Jul 16, 2025Jul 18, 2025View →
ENTX
ENTERA BIO LTD.
PURCHASEGRANT
Stock grant
43,860415,575Jul 16, 2025Jul 18, 2025View →
ENTX
ENTERA BIO LTD.
PURCHASEGRANT
Stock grant
500,000500,000Jul 16, 2025Jul 18, 2025View →
DERM
JOURNEY MEDICAL CORP
PURCHASEGRANT
Stock grant
7,17388,618Jun 25, 2025Jul 7, 2025View →
ENTX
ENTERA BIO LTD.
PURCHASEGRANT
Stock grant
124,121234,873Jul 31, 2024Aug 2, 2024View →
ENTX
ENTERA BIO LTD.
PURCHASEGRANT
Stock grant
500,000500,000Jul 31, 2024Aug 2, 2024View →
DERM
JOURNEY MEDICAL CORP
PURCHASEGRANT
Stock grant
9,72881,445Jul 8, 2024Jul 10, 2024View →
ENTX
ENTERA BIO LTD.
PURCHASE
Chief Executive Officer
23,952$0.71$17.0K110,752Dec 22, 2023Dec 27, 2023View →
ENTX
ENTERA BIO LTD.
PURCHASE
Chief Executive Officer
23,952$0.13$3.0K23,952Dec 22, 2023Dec 27, 2023View →
ENTX
ENTERA BIO LTD.
PURCHASEGRANT
Stock grant
350,000350,000Sep 13, 2023Sep 14, 2023View →
NXGL
NEXGEL, INC.
PURCHASEGRANT
Stock grant
15,00015,000Aug 17, 2023Aug 21, 2023View →
DERM
JOURNEY MEDICAL CORP
PURCHASEGRANT
Stock grant
27,47271,717Jul 21, 2023Jul 25, 2023View →
ENTX
ENTERA BIO LTD.
PURCHASE
Chief Executive Officer
30,000$1.01$30.3K86,800Apr 4, 2023Apr 6, 2023View →
ENTX
ENTERA BIO LTD.
PURCHASE
Chief Executive Officer
50,000$0.53$26.6K56,800Nov 11, 2022Nov 14, 2022View →
ENTX
ENTERA BIO LTD.
PURCHASEGRANT
Stock grant
600,000600,000Sep 7, 2022Sep 9, 2022View →
ENTX
ENTERA BIO LTD.
PURCHASEGRANT
Stock grant
500,000500,000Sep 7, 2022Sep 9, 2022View →
DERM
JOURNEY MEDICAL CORP
PURCHASEGRANT
Stock grant
14,24544,245Jul 21, 2022Jul 25, 2022View →
DERM
JOURNEY MEDICAL CORP
PURCHASEGRANT
Stock grant
30,00030,000Jan 14, 2022Apr 4, 2022View →
ENTX
ENTERA BIO LTD.
PURCHASE
6,800$2.79$19.0K6,800Jan 14, 2022Jan 19, 2022View →
ENTX
ENTERA BIO LTD.
PURCHASEGRANT
Stock grant
107,557107,557Jan 1, 2022Jan 11, 2022View →
ENTX
ENTERA BIO LTD.
PURCHASEGRANT
Stock grant
35,85235,852Jan 1, 2022Jan 11, 2022View →
NXGL
NEXGEL, INC.
PURCHASEGRANT
Stock grant
1,819$0.01$181,819Dec 27, 2021Jan 3, 2022View →
NXGL
NEXGEL, INC.
PURCHASE
1,819$5.49$10.0K1,819Dec 27, 2021Jan 3, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
50,00050,000Jun 25, 2021Jun 29, 2021View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
1,791,5491,791,549Jun 25, 2021Jun 29, 2021View →
Other insiders · DERM
Loading peer insiders…
About this filer
CIK 0001686530
ROLE
Director
PRIMARY
DERM
COMPANIES
4
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001686530DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback